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The well-established E. coli protein production strain
C41(DE3) was isolated from the T7 RNA polymerase-
based BL21(DE3) strain for its ability to produce
difficult recombinant proteins, and it acquired multi-
ple mutations during its isolation. Standard allelic
replacement and competition experiments were
insufficient to de-convolute these mutations. By re-
constructing the evolution of C41(DE3) in real time,
we identified the time frames when the different
mutations occurred, enabling us to link them to parti-
cular stress events. Starvation stress imposed by
the isolation procedure selected for mutations
enhancing nutrient uptake, and protein production
stress formutationsweakening the lacUV5 promoter,
which governs t7rnap expression.Moreover, recapit-
ulating protein production stress in BL21(DE3)
showed that mutations weakening the lacUV5 pro-
moter occur through RecA-dependent recombina-
tion with the wild-type lac-promoter and are selected
for upon the production of any protein. Thus, the
instability of the lacUV5 promoter in BL21(DE3) allevi-
ates protein production stress and can be harnessed
to enhance production.
INTRODUCTION
The bacterium Escherichia coli is the most widely used host to
produce recombinant proteins, and strains with improved pro-
tein production characteristics have been isolated (e.g., Makino
et al., 2011; Massey-Gendel et al., 2009; Miroux and Walker,
1996). However, our knowledge of the genetic adaptations that
enable bacterial strains to efficiently produce proteins is only
scant.
Some two decades ago, the E. coli protein production strain
C41(DE3) was isolated from its parent strain BL21(DE3) for
its ability to produce one particular troublesome recombinant
protein, the mitochondrial oxoglutarate malate carrier protein
(OGCP) (Miroux and Walker, 1996). In BL21(DE3), expression1758 Cell Reports 10, 1758–1766, March 17, 2015 ª2015 The Authorof the gene encoding the target protein is driven by chromoso-
mally encoded T7 RNA polymerase (P), which transcribes eight
times faster than E. coli RNAP (Chamberlin et al., 1970; Iost et
al., 1992; Studier and Moffat, 1986; Figure 1). T7 RNAP specif-
ically recognizes the T7 promoter, which drives the expression
of the target gene from a plasmid (Chamberlin et al., 1970;
Studier and Moffatt, 1986). The gene encoding the T7 RNAP is
under control of the lacUV5 promoter region (PlacUV5), which is
a strong, carbon-catabolite repression protein (CRP)-cAMP in-
dependent variant of the wild-type lac promoter (PlacWT) (Silver-
stone et al., 1970; Wanner et al., 1977; Figure S1). Expression
of the gene encoding the T7 RNAP can be induced with isopro-
pyl-b-D-1-thiogalactopyranoside (IPTG), which leads to expres-
sion of the target gene. Expression of many genes encoding re-
combinant proteins is toxic to BL21(DE3). The expression of the
gene encoding the aforementioned mitochondrial carrier protein
OGCP leads to accumulation of the protein in inclusion bodies
and strongly reduced growth, and as a consequence OGCP
yields are very low (Miroux and Walker, 1996). To improve the
OGCP yields, C41(DE3) was isolated from BL21(DE3) by select-
ing for cells harboring the ogcp expression vector pT7OGCP that
were resistant to IPTG and efficiently produced OGCP (Miroux
and Walker, 1996; Figure 1). Further analysis revealed that
C41(DE3) also produces many other recombinant proteins
more efficiently than its ancestor BL21(DE3), which has made
it a popular host for protein production (Miroux and Walker,
1996). We reasoned that understanding how C41(DE3) had
evolved from BL21(DE3) would increase our knowledge of ge-
netic adaptations that facilitate recombinant protein production
in E. coli.
Sequencing the complete genome of C41(DE3) revealed that
the strain had acquired mutations in four different regions dur-
ing the selection process. All these mutations were linked to
clear phenotypes. Allelic replacement, i.e., swapping mutant
and wild-type loci, and competition experiments are tradition-
ally used to characterize genetic adaptations in bacteria (Con-
rad et al., 2011; Ryall et al., 2012). However, this standard
approach was insufficient to identify the cause and effect of
the multiple mutations that had occurred during the isolation
of C41(DE3) (Miroux and Walker, 1996). To overcome these lim-
itations, we had to reconstruct the isolation of C41(DE3) from
BL21(DE3) in real time, which enabled us to determine thes
Figure 1. The Isolation of C41(DE3) from
BL21(DE3)
C41(DE3) was isolated from the protein production
strain BL21(DE3) for its ability to efficiently pro-
duce OGCP, which is toxic to its ancestor. In
BL21(DE3), expression of the gene encoding T7
RNAP, which drives target gene expression, is
governed by the IPTG-inducible PlacUV5. C41(DE3)
was isolated from BL21(DE3) harboring pT7OGCP
by selecting for IPTG resistance and the ability to
efficiently produce OGCP (Alfasi et al., 2011; Du-
mon-Seignovert et al., 2004; Miroux and Walker,
1996). Sequencing and analysis of the complete
genome of C41(DE3) revealed that during its
isolation it had acquired mutations in four different
regions as follows: (1) three nucleotide substitutions alter PlacUV5 to PlacWeak (Wagner et al., 2008; Figure S1), (2) one single nucleotide substitution in yehU (yehU*)
results in an amino acid exchange in YehU, (3) the IS150 element in rbsD::IS150 is absent and rbsD encodes a full-length protein, and (4) a 5-bp deletion converts
the dcuS pseudogene (dcuS_ps) into a gene encoding full-length DcuS (dcuS) (see Experimental Procedures). For phenotypes linked to the mutations in
C41(DE3), see Figure 2.time frames in which the mutations occurred. These time
frames were key to identifying the selection pressures that
resulted in the isolation of the mutations and, importantly, pro-
vided the filter to capture the mutations responsible for the
improved protein production behavior of C41(DE3). By eluci-
dating how these key mutations for the production of
recombinant proteins occurred, we discovered that the inherent
genetic instability of BL21(DE3) has been commonly exploited
for years to alleviate protein production stress and enhance
yields without our knowledge.
RESULTS
Sequencing of the C41(DE3) Genome and Phenotypes
of Its Acquired Mutations
Sequencing the genome of C41(DE3) and subsequently
comparing it to the one of its ancestor BL21(DE3) revealed that
C41(DE3) had accumulated mutations in four separate regions
during its isolation (Figure 1). Besides the mutations in PlacUV5,
we identified mutations in yehU, rbsD::IS150, and dcuS_ps. As
shown previously, themutations altering PlacUV5 to PlacWeak result
in strongly reduced T7 RNAP levels upon the addition of IPTG in
C41(DE3) (Wagner et al., 2008; Figure 2A). yehU encodes a
sensor histidine kinase, which, together with the response regu-
lator YehT, positively regulates the expression of the gene en-
coding the putative peptide transporter YjiY (Kraxenberger
et al., 2012). The substitution of one nucleotide in yehU (yehU*)
leads to an amino acid exchange in YehU, which results in high
accumulation levels of YjiY in C41(DE3) (Figure 2B). rbsD en-
codes ribose pyranase, a protein involved in ribose catabolism
(Ryu et al., 2004; Figures 2C and S2A). In BL21(DE3), rbsD is in-
activated by an IS element (rbsD::IS150). In C41(DE3), rbsD lacks
this IS element and its open reading frame (ORF) is restored,
which enables this strain to efficiently use ribose as its sole
carbon and energy source (Figures 2C, S2B, and S2C). The
DcuS/R two-component sensory system regulates the expres-
sion of genes involved in the uptake andmetabolism of C4-dicar-
boxylates like succinate (Golby et al., 1999; Figures 2D and S2D).
In BL21(DE3), dcuS is a pseudogene (dcuS_ps) and the strain
grows poorly on minimal medium containing C4-dicarboxylatesCellas the sole carbon and energy source. Due to a deletion of five
base pairs, C41(DE3) harbors a full-length dcuS ORF, which
enables the efficient growth on minimal medium containing
C4-dicarboxylates (Figures 2D, S2E, and S2F). Thus, rbsD and
dcuS enable C41(DE3) to efficiently utilize an extended array
of carbon and energy sources. If YjiY is indeed a peptide
transporter, also the mutation affecting yehU could extend the
array of carbon, energy, and even nitrogen sources available to
C41(DE3).
Notably, C41(DE3) was isolated on rich 23TY medium, and
protein production requires the excessive input of the afore-
mentioned resources. Thus, it seemed likely that the identified
mutations promote protein production. However, allelic
replacement experiments could only link the mutations in
PlacUV5 to the ability of C41(DE3) to efficiently produce OGCP
and other recombinant proteins (Figures 3 and S3). Despite
clear phenotypes, standard allelic replacement and competi-
tion experiments did not provide an answer to the question of
why the different mutations had been selected for during the
isolation of C41(DE3) (Figure S3; data not shown). This neces-
sitated the design of an alternative strategy to de-convolute
them.
Reconstructing the Evolution of BL21(DE3) to C41(DE3)
in Real Time
We reasoned that the time frames in which the genetic adapta-
tions in C41(DE3) had occurred may help to decipher their role.
To identify these time frames, we reconstructed the isolation
of C41(DE3) in real time and followed the occurrence of the
identified mutations (Figure 4A).
The isolation of C41(DE3) consisted of two steps. In the first
step, BL21(DE3) harboring pT7OGCP, which confers resistance
to ampicillin, was grown in liquid culture, and ogcp expression
was induced with IPTG. Subsequently, clones were isolated
that were resistant to IPTG and ampicillin on plate. These clones
were tested for the ability to efficiently produce OGCP upon the
addition of IPTG to liquid culture. During the second step, clones
that efficiently produced OGCP were cured from pT7OGCP
(Miroux and Walker, 1996). The reconstruction linked the isola-
tion of IPTG-resistant clones in the first step to the mutationsReports 10, 1758–1766, March 17, 2015 ª2015 The Authors 1759
Figure 2. Phenotypes Linked to the Muta-
tions in C41(DE3)
(A) In C41(DE3), PlacUV5 has acquired three muta-
tions (Wagner et al., 2008) (indicated in boldface).
These weaken the promoter as shown by the
strongly reduced T7 RNAP levels in C41(DE3)
upon the addition of IPTG. The insets represent
immunoblotting experiments using a monoclonal
T7 RNAP antibody (see Experimental Procedures).
(B) The YehU/T response regulator system regu-
lates expression of the gene encoding the putative
peptide transporter YjiY (Kraxenberger et al.,
2012). One non-synonymous point mutation in
yehU leads to increased accumulation levels of
YjiY in C41(DE3). Shown are the levels of native,
chromosomally encoded YjiY equipped with a
C-terminal His-tag (YjiY-Hischrom). The insets
represent immunoblotting experiments using
the HisProbe antibody (see Experimental Pro-
cedures).
(C) rbsD encodes a ribose pyranase, which
converts b-D-ribopyranose to b-D-ribofuranose,
the first step in E. coli ribose catabolism (Ryu
et al., 2004). The presence of an IS element
(IS150) in rbsD prevents efficient growth of
BL21(DE3) on ribose as its sole carbon and energy source. In C41(DE3) IS150 is absent, enabling efficient growth on ribose.
(D) dcuS encodes the sensor histidine kinase of the DcuS/DcuR two-component regulatory system. This system regulates the expression of genes that are, like
dctA, involved in uptake and utilization of C4-dicarboxylates (Golby et al., 1999). BL21(DE3) harbors dcuS containing an internal stop codon (dcuS_ps) and cannot
efficiently utilize C4-dicarboxylates, such as succinate, as its sole carbon and energy source. A 5-bp deletion in dcuS_ps establishes a full-length dcuS ORF
inC41(DE3), which allows the efficient utilization of C4-dicarboxylates. For supporting information on themutations in rbsD::IS150 and dcuS_ps, see Figures S2A–
S2F, respectively. CM, cytoplasmic membrane.changing PlacUV5 to PlacWeak (Figures 4B, S4A, and S4B). This is in
keeping with the critical role of thesemutations in OGCPproduc-
tion (Figure 3).
IPTG-resistant clones were isolated on agar plates containing
IPTG and ampicillin, as described in the Experimental Proce-
dures. Notably, the addition of IPTG to the culture was not
needed for the occurrence of these mutations, as we were
able to pick up IPTG-resistant clones carrying PlacWeak also
before the addition of inducer (Figures 4B and S4B). Rather,
the addition of IPTG resulted in a pronounced enrichment of
these clones. Before induction, the IPTG-resistant cells repre-
sented only a very small fraction of the cells that were resistant
to ampicillin, i.e., the majority of cells that had retained
pT7OGCP did not form colonies in the presence of inducer. In
contrast, 3 hr after the addition of IPTG, the fraction of IPTG-
resistant cells had increased markedly (Figures 4B and S4B),
which is in keeping with IPTG being the selection agent rather
than causing the mutations. None of the other mutations could
be detected in these clones (data not shown). However, during
the subsequent plasmid curing step, the clones isolated in the
first step acquired the ability to efficiently utilize ribose andC4-di-
carboxylates in waves (Figures 4C, S4D, and S4E). In all cases
tested, the ability to use ribose was linked to the loss of IS150
from rbsD::IS150. In one-third of the tested clones that were
able to grow efficiently on C4-dicarboxylates, dcuS had been
restored as in C41(DE3) (data not shown). These traits also arose
in cultures of plain BL21(DE3). Thus, the ability of C41(DE3) to
utilize ribose and C4-dicarboxylates is not linked to protein pro-
duction, but rather to the need to scavenge for nutrients during1760 Cell Reports 10, 1758–1766, March 17, 2015 ª2015 The Authorthe prolonged incubation in the closed setup used to cure the
cells from pT7OGCP.
We did not isolate clones carrying the single point mutation in
yehU. It is possible that this mutation in yehU did not confer any
growth advantage, but was isolated by chance. In this context, it
is noteworthy that the spontaneous mutation rate for E. coli has
been estimated to be approximately 1–43 103 per genome per
generation for cells cultured under standard laboratory condi-
tions (Drake, 1991; Lee et al., 2012). However, it should be noted
that the spontaneous mutation rate appears to be stress depen-
dent (e.g., Maharjan and Ferenci, 2015).
Taken together, reconstructing the isolation of C41(DE3) from
BL21(DE3) in real time enabled us to assign the presence of
rbsD and dcuS in C41(DE3) to the culture conditions used during
the plasmid curing step. Furthermore, it ultimately showed that
the mutations changing PlacUV5 to PlacWeak cause IPTG resis-
tance and are critical for the efficient production of OGCP.
Occurrence of the PlacUV5 Mutations
Our ability to isolate IPTG-resistant clones carrying PlacWeak
already before the addition of IPTG to the culture prompted us
to investigate the earliest possible time point at which such
mutants can be picked up. To this end, BL21(DE3) was trans-
formed with pT7OGCP, and, at defined time points, a portion
of the transformation mixtures was spread on agar plates con-
taining both ampicillin and IPTG. Notably, IPTGwas only present
in the selection plates and not in the transformation mixtures.
Within hours after the transformation, portions of these mixtures
gave rise to IPTG-resistant clones on plate. Part of the testeds
Figure 3. The Efficient Production of OGCP in C41(DE3) Does Not Require yehU*, rbsD, and dcuS
(A) To determine which mutations facilitate the production of OGCP, C41(DE3) (trace 1), BL21(DE3) (traces 2 and 2*), C41(DE3)yehU/rbsD::IS150/dcuS_ps
(trace 3), and C41(DE3)PlacUV5 (traces 4 and 4*) were transformed with pT7OGCP, and the expression of ogcp was induced as described in the Experimental
Procedures. Arrows indicate the addition of IPTG. Compared to C41(DE3), only the growth of BL21(DE3) and C41(DE3)PlacUV5 was severely impaired prior to
and after the addition of IPTG. It should be noted that the growth behavior of strains harboring PlacUV5 was variable. Therefore, growth data for strains 1 and 3 are
shown as mean ± SD (n = 3); the two most extreme growth curves are shown for BL21(DE3) (traces 2 and 2*) and C41(DE3)PlacUV5 (traces 4 and 4*).
(B) Three hours after the induction of ogcp expression, cells were harvested and inclusion bodies isolated to monitor OGCP production. Cultures of cells
containing PlacUV5 produced considerablymoreOGCP in inclusion bodies per A600 unit as compared to cultures of cells with PlacWeak.M,molecular weight marker.
(C) Summary of the findings presented in (A) and (B). Cells carrying PlacUV5 producemore OGCP in inclusion bodies per A600 unit than cells with PlacWeak. However,
cells carrying PlacWeak produce considerablymore biomass than cells with PlacUV5. As a result, cultures of cells with PlacWeak yieldmoreOGCP than cultures of cells
with PlacUV5. These observations were confirmed using two other proteins and the results are, together with control experiments, presented in Figure S3.clones had acquired the same three mutations in PlacUV5 as
C41(DE3), whereas all the other tested clones had retained
PlacUV5 (Figure 5A). This observation, together with the strongly
impaired growth of BL21(DE3) containing pT7OGCP and the
isolation of mutants carrying PlacWeak even before the addition
of IPTG to the culture (Figure S5A), suggest that leaky back-
ground expression of ogcp already very early on can promote
the selection of IPTG-resistant clones carrying these mutations.
To determine if the occurrence of mutations changing PlacUV5
to PlacWeak is specific for OGCP, we used green fluorescent pro-
tein (GFP) as a control. Growth of BL21(DE3) harboring the gfp
expression plasmid pT7GFP is less affected prior to and after
the addition of IPTG than growth of BL21(DE3) harboring
pT7OGCP (Figure S5A). However, the mutations changing
PlacUV5 to PlacWeak also could be identified in clones derived
from BL21(DE3) harboring pT7GFP prior to and 3 hr after the in-
duction of gfp expression (Figures 5B and S5B–S5D). Notably, all
large, weakly fluorescent IPTG-resistant colonies had retained
PlacUV5, indicating that these cells had acquired other mutations
to cope with protein production stress. All small, highly fluores-
cent colonies tested had acquired mutations altering PlacUV5 to
PlacWeak (Figure 5B, right, but see also the next section). This
distinct phenotype enabled the rapid identification of
BL21(DE3)-derived clones containing PlacWeak on plate.
Also when starting directly from a transformation, the behavior
of BL21(DE3) transformed with pT7GFP resembled that of
BL21(DE3) harboring pT7OGCP (Figures 5C–5E and S5E).Within
hours after the transformation, relative to the number of cells
resistant to ampicillin (i.e., carrying pT7GFP), only a small frac-
tion of cells gave rise to IPTG-resistant clones on plate. Both
3 hr after the addition of IPTG and when starting from a transfor-
mation mixture, the percentage of the IPTG-resistant clones
carrying PlacWeak rather than PlacUV5 varied widely. However,Cellupon induction with IPTG, clones carrying PlacWeak were domi-
nant (i.e., >50%) in 20 of the 22 tested cultures (Figure 5C).
The change of PlacUV5 to PlacWeak using both OGCP and GFP
raised the question of whether stress due to the synthesis of
T7 RNAP itself rather than the production of the target protein
is sufficient to isolate IPTG-resistant clones carrying PlacWeak.
To address this question, we used variants of pT7GFP and
pT7OGCP in which the T7 promoter was replaced by a random
sequence (Figure S5F). BL21(DE3) cells harboring these plas-
mids, just like C41(DE3), grew readily in liquid culture prior to
and after the addition of IPTG, and, under both conditions,
resembled the behavior of C41(DE3) on agar plates supple-
mented with ampicillin and IPTG (Figures S5G and S5H). These
cells also were able to form colonies on IPTG-containing agar
plates a few hours after transformation (Figures 5D and 5E).
Thus, it is not the synthesis of T7 RNAP itself but rather its action
on the T7 promoter-based expression plasmid that enables the
isolation of cells carrying PlacWeak.
Taken together, these data show that stress imposed on
BL21(DE3) cells harboring a T7-expression vector containing
ogcp or gfp enables the selection of BL21(DE3) derivatives car-
rying PlacWeak.
Mechanism Driving the Mutations in PlacUV5
In all but two of the more than 150 tested BL21(DE3)-derived
clones in which PlacUV5 was mutated, it had changed to PlacWeak,
which represents PlacWT in the 10 region and the O1-operator,
and PlacUV5 in the CRP-binding region (Figure S1). In the two ex-
ceptions, only the10 region had changed to the corresponding
bases in PlacWT. This specific change, together with the isolation
of clones carrying PlacWeak within hours after transformation,
suggested a recombination event between the native chromo-
somal PlacWT and PlacUV5. It is known that there is continuousReports 10, 1758–1766, March 17, 2015 ª2015 The Authors 1761
Figure 4. Reconstructing the Evolution of C41(DE3) from BL21(DE3) in Real Time
(A) The isolation of C41(DE3) from BL21(DE3) harboring pT7OGCPwas reconstructed as follows: (1) IPTG-resistant clones that had retained pT7OGCP (i.e., were
ampicillin resistant) were isolated from a culture of BL21(DE3)/pT7OGCP; and (2) these clones were subsequently cultured in 23TY medium containing IPTG
for 7 days,mimicking the plasmid curing step described by (Miroux andWalker, 1996). Data in (B) and (C) are represented in semi-log scale box-and-whisker plots
to account for the observed variation (see Experimental Procedures).
(B) Even before the addition of IPTG, 0.9% of the ampicillin-resistant CFUs were already resistant to IPTG; 3 hr after induction, the number of IPTG-resistant
CFUs had increased to78% (yellow boxes). C41(DE3) was included as control (gray boxes). In this experiment, 15 of 18 randomly picked, IPTG-resistant clones
contained the same mutations in PlacUV5 as C41(DE3), whereas three had retained PlacUV5 (for examples, see Figure S4C).
(C) The 18 clones were subsequently cultured for 7 days in 23TY medium (step 2). Every day, the cultures were screened for the presence of cells able to grow
on M9 minimal medium plates containing 0.1% ribose (left plot) or 0.1% of the C4-dicarboxylate succinate (right plot). The number of CFUs on the respective
carbon source was compared to the total numbers of CFUs on 23TY plates. For original data, see Figure S4.recombination between homologous regions in bacterial ge-
nomes and that upon stress the frequency of this process can
increase. Notably, PlacUV5 is flanked by regions (>400 bp) that
are homologous to the native lac locus, which is expected to
greatly facilitate recombination (Watt et al., 1985).
To test if the mutation of PlacUV5 to PlacWeak is indeed driven
by the recombination of PlacUV5 with PlacWT, we constructed a
BL21(DE3) derivative lacking PlacWT, BL21(DE3)DPlacWT. This
strain and, as a control, BL21(DE3) were transformed with
pT7GFP. Three hours after inducing gfp expression in liquid cul-
ture, the cultures were assayed for the presence of IPTG-resis-
tant clones. Confirming previous results, in all tested small and
highly fluorescent colonies originating from BL21(DE3), PlacUV5
had changed to PlacWeak (Figures 6A [lane 1] and S6A). Also for
BL21(DE3)DPlacWT we were able to isolate highly fluorescent
colonies. However, none of these had obtained the mutations
in PlacUV5 (Figures 6A [lane 2] and S6A). Complementing this
strain with PlacWT on a plasmid again gave rise to small, highly
fluorescent colonies in which PlacUV5 had mutated to PlacWeak
(Figures 6A [lane 3] and S6A). This indicates that the change
from PlacUV5 to PlacWeak is driven by recombination with PlacWT.
In E. coli, the majority of recombination events involve the1762 Cell Reports 10, 1758–1766, March 17, 2015 ª2015 The Authorrecombinase RecA (Camerini-Otero and Hsieh, 1995). Indeed,
in a BL21(DE3) derivative lacking RecA, we were unable to iden-
tify colonies in which PlacUV5 had mutated to PlacWeak (Figures 6A
[lane 4] and S6B).
If the mutation from PlacUV5 to PlacWT in BL21(DE3) is recombi-
nation driven, we wondered why we did not pick up any clone
harboring a complete reversion to PlacWT. Interestingly, when
using BL21(DE3)pLysS, a BL21(DE3) derivative in which the
bulk activity of T7 RNAP is reduced by its natural inhibitor T7
lysozyme, we were able to isolate IPTG-resistant clones where
PlacUV5 had entirely reverted to PlacWT (Moffatt and Studier,
1987; Figures 6B and S6C–S6E). In contrast to PlacWeak, tran-
scription from PlacWT is stimulated by CRP-cAMP (Wanner
et al., 1977; Figure S1). In keeping with this, colonies formed
by clones carrying PlacWT were markedly smaller than those
formed by clones carrying PlacWeak. These results indicate that
only lowering bulk T7 RNAP activity allows the isolation of clones
carrying PlacWT, which explains why we did not pick up such
clones when using plain BL21(DE3) (see also Figure S6).
Taken together, these results show that RecA-dependent
recombination drives the conversion from PlacUV5 to PlacWeak
and PlacWT.s
Figure 5. Occurrence of the Mutations Changing PlacUV5 to PlacWeak
(A) The occurrence of IPTG-resistant clones of BL21(DE3)/pT7OGCP was monitored starting directly from the transformation. Only a few hours after trans-
formation (in this particular example, at 3 hr), we picked up IPTG-resistant clones in which PlacUV5 had mutated to PlacWeak.
(B) Expression of gfp was induced in BL21(DE3)/pT7GFP for 3 hr and the culture was assayed for the presence of IPTG-resistant cells (see Experimental Pro-
cedures). (Left) An image of a plate with IPTG-resistant colonies under ambient light is shown. (Right) An overlay of the ambient light image with its fluorescence-
based image is shown. Fluorescence levels are displayed in a heat-map format (dark blue, background fluorescence; red, highest fluorescence levels). In all
small, highly fluorescent colonies, PlacUV5 hadmutated to PlacWeak (black arrows), whereas all analyzed big, weakly fluorescent colonies had retained PlacUV5 (white
arrows).
(C) The percentages of IPTG-resistant colonies isolated from cultures of BL21(DE3)/pT7GFP 3 hr after induction with IPTG and at their first occurrence after
transformation are shown. Each dot represents one experiment; the median is indicated with a red bar.
(D) Replacing the T7 promoter of pT7GFP for a random sequence alleviates toxity as shown by the unimpaired ability of serial diluted BL21(DE3)/pT7-randGFP
cultures to formcoloniesonagarplates containing IPTGandampicillin 5 hr after transformationascompared toBL21(DE3) harboringunalteredpT7GFP.C41(DE3)/
pT7GFP is shown as a control. Note that the color scale is slightly compressed relative to (B) due to camera settings (background fluorescence, light blue).
(E) Also BL21(DE3)/pT7-randOGCP readily forms colonies on agar plates containing IPTG and ampicillin, in contrast to BL21(DE3)/pT7OGCP. For supporting
data, refer to Figure S5.The Selection for Mutations in the lacUV5 Promoter
Region Is Target Independent
The results obtained with OGCP and GFP suggested that, when
using the BL21(DE3)/T7 vector system to produce a protein, the
selection of IPTG-resistant clones in which PlacUV5 had con-
verted to either PlacWeak or PlacWT is target independent. When
we recapitulated protein production stress in BL21(DE3) using
seven additional targets destined either for the cytoplasm, the
cytoplasmic membrane, or the periplasm, IPTG-resistant clones
carrying PlacWeak or PlacWT rather than PlacUV5 could be isolated
for all targets (Figure 6C; Table S1). Such clones could even be
isolated from a culture of BL21(DE3) harboring a T7-based vec-
tor containing a variant of the gfp gene that lacks the start codon
(Table S1). Thus, IPTG-resistant clones in which PlacUV5 has
converted to PlacWeak or PlacWT can be selected in a target-
independent manner, and even the production of mRNA from a
T7-based expression vector might contribute to the selection
of such mutants.
DISCUSSION
When attempting to assign functions to the multiple mutations
in the well-established protein production strain C41(DE3)
using standard allelic replacement and competition experiments
(Conrad et al., 2011; Ryall et al., 2012), we were confronted withCellthe limitations of these approaches. They do not provide any
information concerning the time frames when mutations occur,
which may be critical to assigning functions to mutations,
especially if the stressor promoting their selection is not obvious
(Ryall et al., 2012). Furthermore, only when alleles are stably
maintained during competition experiments, the results of
these experiments can be used to assign functions to mutations.
In our study, we found that by reconstructing an evolutionary
event in real time, which provides information concerning the
time frames when mutations occur, the limitations of the afore-
mentioned approaches can be overcome.
During its isolation from BL21(DE3), C41(DE3) had acquired
mutations in four different regions. By reconstructing the isola-
tion of C41(DE3) in real time, we identified the time frames in
which the different mutations had occurred. This information
was critical to link the mutations enhancing the uptake of
ribose and C4-dicarboxylates in C41(DE3) to starvation stress
imposed by the isolation procedure used. Furthermore, it
enabled us to unambiguously link the mutations weakening
PlacUV5 to protein production stress and show that they are
solely responsible for the improved protein production charac-
teristics of C41(DE3). This provided the framework for showing
that mutations weakening PlacUV5 occur through RecA-depen-
dent recombination with the native PlacWT and are selected for
independently of the target (Figures 6C and 6D). Thus, 30 yearsReports 10, 1758–1766, March 17, 2015 ª2015 The Authors 1763
Figure 6. The Change of PlacUV5 to PlacWeak
or PlacWT Is Driven by RecA-Dependent
Recombination between PlacUV5 and PlacWT
and Is Target Independent
(A) The effect of the absence of PlacWT and recA on
the occurrence of clones harboring PlacWeak was
studied using pT7GFP. As shown in Figure 5B,
colonies formed by IPTG-resistant derivatives
of BL21(DE3) harboring pT7GFP show distinct
phenotypes that allowed to discriminate clones
carrying PlacUV5 (white arrows) or PlacWeak (black
arrows). The change fromPlacUV5 to PlacWeak occurs
inBL21(DE3)when thenativePlacWT locus ispresent
on the chromosome (lane 1), but not in a strain in
which it has been deleted (BL21(DE3)DPlacWT) (lane
2). When BL21(DE3)DPlacWT is transformed with a
plasmidcontainingPlacWeak, thechangeofPlacUV5 to
PlacWeak can occur again (lane 3). In cells lacking
recA, no PlacUV5 mutations were picked up (lane 4).
(B) Only when using BL21(DE3)pLysS, but not
BL21(DE3), we could isolate IPTG-resistant col-
onies in which PlacUV5 had completely reverted
to PlacWT. For supporting data, see Figure S6.
The colonies shown are representative examples
of the observed phenotypes linked to the listed
genotypes.
(C) BL21(DE3)-derived clones carrying PlacWeak or PlacWT rather than PlacUV5 are selected for independent of the target and the compartment for which it is
destined (Cyto, cytoplasm; Peri, periplasm; CM, cytoplasmic membrane). For details, refer to Table S1.
(D) Model for the RecA-mediated conversion of PlacUV5 to PlacWeak and PlacWT.after the introduction of the E. coli BL21(DE3)/T7 vector system,
our study provides an answer to the question of why BL21(DE3)-
derived protein production clones often differ in stability and,
consequently, in protein production yields. Moreover, it shows
that, when using BL21(DE3), the isolation of clones carrying
PlacWeak as reported by Miroux and others is not a coincidence
(Alfasi et al., 2011; Dumon-Seignovert et al., 2004; Miroux and
Walker, 1996).
The isolation of C41(DE3) is an example of how genetic insta-
bility can be exploited to improve protein production. However,
reducing the strength of an expression system used to drive
recombinant protein production also can have a negative effect
on production yields. Therefore, if a modified native promoter
system fulfills a key role in a protein production system, host
backgrounds with and without the native promoter system
should be included in production screens. Based on our obser-
vations, such a setup should provide information as to how to
optimize the production of recombinant proteins. When using
BL21(DE3), the lac-promoter variants governing t7rnap expres-
sion that one can obtain through homologous recombination
are limited to sequence combinations of PlacUV5 and PlacWT.
It is very well conceivable that these sequences do not allow
the creation of the optimal promoter for the production of a
particular recombinant protein. Therefore, the use of promoter
mutant libraries for recombination may be explored.
Taken together, our study provides new leads for designing
strategies to optimize the production of recombinant proteins.
In addition, we envisage that the de-convolution of mutations
by their real-time reconstruction will help to further our under-
standing of evolutionary events in both pro- and eukaryotic
systems.1764 Cell Reports 10, 1758–1766, March 17, 2015 ª2015 The AuthorEXPERIMENTAL PROCEDURES
Genome Sequencing and Analysis
A culture of the E. coli strain C41(DE3) was grown to the exponential phase
using standard conditions (seeCulture andGene ExpressionConditions). Cells
were harvested and genomic DNA was isolated using the DNeasy Blood & Tis-
sue Kit (QIAGEN) following the instructions of the manufacturer. An on-column
RNase treatment step was included in the isolation procedure. The complete
genome of C41(DE3) was sequenced using Roche454 pyro-sequencing with
TitaniumFlex Chemistry with an average coverage of 43. The 454 sequencing
data were assembled using Newbler (Roche). Remaining gaps were closed
using standard PCR/Sanger sequencing. The assembled sequence was sub-
mitted to GenBank where it was annotated. The genome of C41(DE3) was
compared to the genome of its ancestor BL21(DE3) (GenBank accession num-
ber CP001509.3) (Jeong et al., 2009) using Stand-alone BLAST (e.g., Camacho
et al., 2009). Differences compared to the reference genome were confirmed
by PCR/Sanger sequencing. The mutated loci in the C41(DE3) genome were
compared to the corresponding loci in C43(DE3), which was directly derived
from C41(DE3) (Miroux and Walker, 1996). This identified PlacWeak, yehU*,
rbsD, and dcuS as the loci that are linked to the isolation of C41(DE3).Strains and Strain Construction
E. coli strains BL21(DE3), C41(DE3), and derivatives thereof, as well as
BL21(DE3)pLysS and BLR were used in this study (see Table S2). To investi-
gate the role of the mutations in C41(DE3), they were introduced into
BL21(DE3) and their wild-type counterparts were introduced in C41(DE3) using
a Red-swap-method-based approach (Datsenko and Wanner, 2000). In short,
a gene that is in close proximity (%10 kb distance) to the sequence to be trans-
ferred, and whose deletion would not lead to a markedly changed phenotype
under the conditions used (Nichols et al., 2011), was used for the integration
of a kanamycin cassette into the chromosome. Kanamycin-resistant clones
(kan: 50 mg/ml final concentration) were investigated for the proper insertion
of the kanamycin cassette by PCR/sequencing. Gene deletions were made
following the Red swap method (Datsenko and Wanner, 2000). Strains that
were exposed to the lambda Red system were not used directly for furthers
experiments, but the region of interest was transferred to a strain not exposed
to the lambda Red system using P1-mediated generalized transduction to
minimize the risks of side effects of the experimental procedure used (i.e.,
unintended mutations) (Miller, 1972). Upon successful transduction of the
genetic region of interest, the kanamycin cassette was removed from the
genome of the recipient strain using the FLP-recombinase (Datsenko and
Wanner, 2000). If feasible, kanamycin cassettes for target genes for the
transfer of chromosomal sequences between strains and for gene deletions
were amplified directly from the Keio collection. BL21(DE3) yjiY-hischrom and
C41(DE3) yjiY-hischrom were constructed by inserting the genetic information
encoding a 6xHis-tag in between the last coding codon and the stop codon
of yjiY using a modified version of the Red swap method. See Table S2 for
more information on the constructed strains and Table S3 for the sequences
of the primers used to construct them.
Plasmids
For plasmids used in this study see Table S4. Primers pT7scram_f (50 GAGA
GAGTGTCTCTGACTCGAGACCACAACGGTTTCCC 30) and pT7scram_r
(50 GAGTCAGAGACACTCTCTCATTTCGCGGGATCGAGATC 30) were used
to construct pT7-randOGCP and pT7-randGFP. For protein production exper-
iments, plasmids were transformed into chemically competent cells (CaCl2).
For pKD46 and pCP20 (see Table S4) electrocompetent cells were used.
Culture and Gene Expression Conditions
If not specified otherwise, cells were cultured aerobically at 37C and 200 rpm
in an Innova 480 shaker (liquid culture). To minimize clonal variation, fresh
colonies were used. Lysogeny broth (LB) medium was prepared according
to the instructions of themanufacturer (Difco Laboratories). The 23TYmedium
was composed of 16 g/l tryptone (Difco), 10 g/l yeast extract (Difco), and 5 g/l
NaCl. M9 minimal medium was composed of 13M9-salts, 13 trace elements
(Studier, 2005), 1 mM Mg2SO4, 0.1 mM CaCl2, 0.1 mM biotin, and ribose, suc-
cinate, malate, aspartate, lactate, or glucose as indicated. Amp (100 mg/ml
final concentration), kan (50 mg/ml final concentration), or cam (34 mg/ml final
concentration) were added as specified. IPTG was added to a final concentra-
tion of 0.7 mM (for the expression of ogcp/gfp/oscp and all targets in Table S1;
compare also Miroux and Walker, 1996) or 0.4 mM (expression of yidC-gfp,
see Figures S3C and S3D; compare also Wagner et al., 2007).
Isolation of IPTG-Resistant Clones on Plate and Sequencing
the PlacUV5 Region
For the isolation of IPTG-resistant clones, a portion of the culture was serial
diluted (a factor of 10 between each step), and the different dilutions were
spread on 23TY agar plates supplemented with 0.7 mM IPTG and the respec-
tive antibiotic. Plates were incubated at 37C. To determine if the isolated
colony-forming units (CFUs) carried PlacUV5, PlacWeak, or PlacWT, the respective
region was amplified by PCR using the primers U_lacUV5 (sequence: TTA ATG
CAG CTG GCA CGA C) and D_T7RNAP (sequence: TGC ATC TAC TCG TCG
CGA AC) and sequenced by regular Sanger sequencing. The occurence of
IPTG-resistant clones directly after transformation was assayed. Cells were
transformed with the plasmid and allowed to recover for 1 hr at 37C. Subse-
quently, medium containing 100 mg/ml ampicillin was added and cultivation
continued at 37C. At different time points, a portion of this culture was
withdrawn and spread (or spotted, see Figures 5D and 5E) on agar plates
containing IPTG and ampicillin.
Assaying Growth on Different Carbon Sources
The ability of strains to grow on different carbon sources (see Figures 2, 4, S2,
and S4) was determined. Overnight cultures of respective strains were diluted
1:100 in LB medium. After 12 hr, a serial dilution of each culture was spotted
onto M9 minimal medium plates containing a specific carbon and energy
source and on LB plates (control). Plates were incubated at 37C. Concentra-
tions of carbon sources were as follows: ribose 0.1%; succinate, malate,
aspartate, lactose, and glucose 0.5%.
Spot Assays
For spot assays, cultures were serial diluted in 13M9 salts or PBS (a factor of
10 between each step). Cells that were to be spotted on M9 minimal mediumCellplates were harvested and washed once with 13M9 salts or PBS prior to dilu-
tion. A volume of 4 ml was used for spotting.
Inclusion Body Isolation and Analysis
Inclusion bodies were isolated essentially as described before (Wagner et al.,
2007). Protein concentrations in whole-cell lysates and the inclusion body
fractions were determined using a BCA assay according to the instructions
of the manufacturer (Pierce). A total of 10 mg protein per lane was analyzed
by standard SDS-PAGE followed by Coomassie staining.
Monitoring Levels of YidC-GFP
Accumulation levels of YidC-GFP were monitored using whole-cell fluores-
cence as described before (Drew et al., 2006). Briefly, cells from 1 ml culture
were harvested, washed once with 13PBS, and resuspended in 100 ml 13
PBS. Fluorescence was measured using a SpectraMax GeminiEM (Molecular
Devices) at an excitation wavelength of 488 nm and an emission wavelength
of 510 nm.
Immunoblotting
SDS-PAGE and immunoblotting were performed essentially as described
before (Wagner et al., 2007). 0.05 A600 units were loaded per lane. YjiY-Hischrom
was detected using the HisProbe-HRP-conjugated antibody (Thermo
Scientific). T7 RNAP was detected using a monoclonal mouse-anti T7 RNAP
antibody primary antibody (Novagen) and a goat anti-mouse IgG (H+L)-HRP-
conjugated secondary antibody (Bio-Rad).
Box-and-Whisker Plots
Data presented in Figure 4 are shown in box-and-whisker plots rather than
mean ± SD bar graphs to account for observed variations between the single
cultures. Boxes show the first quartile, median, and third quartile according
to standard conventions; whiskers extend to the extremes. Cultures that did
not give rise to any colonies under the tested conditions were included in
the calculations; however, for graphical display using a semi-log plot scale,
0 was replaced by 1E-5.
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